Trial Profile
A Phase 1b, Randomized, Blinded, Placebo-Controlled Study toEvaluate the Effect of Selonsertib on Renal Function as Assessedby Markers of Glomerular Filtration Rate in Subjects with ChronicKidney Disease
Status:
Recruiting
Phase of Trial:
Phase I
Latest Information Update: 02 Jul 2019
Price :
$35
*
At a glance
- Drugs Selonsertib (Primary) ; Iohexol
- Indications Renal failure
- Focus Therapeutic Use
- Sponsors Gilead Sciences
- 22 Aug 2018 New trial record